The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: A systematic review

International Journal of Evidence-Based Healthcare

Volumn 14, Issue 2, 2016, Pages 53-63

  Atlantis, Evan ^a,b   Cochrane, Belinda ^a,c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c NONE   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Diet; Fatty acids; Omega 3; Omega 6; Supplement

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

DIETARY SUPPLEMENT; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 84975270782     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1097/XEB.0000000000000056     Document Type: Review

References (32)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
2. Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013; 198: 144-8.
3. Access Economics Pty Limited. Economic impact of COPD and cost effective solutions. 2008.
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and pre-vention of chronic obstructive pulmonary disease (Revised 2011). 2011.
5. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-21.
6. Hogg JC, Chu F, Utokaparch S, et al. The nature of smallairway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-53.
7. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-75.
8. Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995-2004.
9. Chang C, Zhu H, Shen N, et al. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD: a longitudinal and cross-sectional study. J Chronic Obstruct Pulmon Dis 2015; 12:19-30.
10. Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006; 83 (6 Suppl): 1520S-5.
11. Mann J, Truswell AS. Essentials of human nutrition. 3rd ed. Oxford: Oxford University Press; 2007.
12. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001; 23: 268-87.
13. de Batlle J, Sauleda J, Balcells E, et al. Association between 3 and 6 fatty acid intakes and serum inflammatory markers in COPD. J Nutr Biochem 2012; 23: 817-21.
14. Poudel-Tandukar K, Nanri A, Matsushita Y, et al. Dietary intakes of a-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. Nutr Res 2009; 29:363-70.
15. Niu K, Hozawa A, Kuriyama S, et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006; 84: 223-9.
16. Julia C, Touvier M, Meunier N, et al. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E as an effect modifier. J Nutr 2013; 143: 1760-6.
17. Li K, Huang T, Zheng J, et al. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor alpha: a meta-analysis. PLoS One 2014; 9: e88103.
18. Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and shortterm prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 2012; 142: 1126-33.
19. Broekhuizen R, Wouters EFM, Creutzberg EC, et al. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005; 60: 376-82.
20. McKeever TM, Lewis SA, Cassano PA, et al. The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax 2008; 63: 208-14.
21. Atlantis E, Cochrane B. The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity outcomes in chronic obstructive pulmonary disease: a systematic review protocol. JBI Database Syst Rev Implement Rep 2014; 12:197-211.
22. The Joanna Briggs Institute. Joanna Briggs Institute Review-ers' Manual: 2014 edition. The Joanna Briggs Institute; 2014.
23. National Health and Medical Research Council (NHMRC). NHMRC additional levels of evidence and grades for recom-mendations for developers of guidelines STAGE 2 CONSUL-TATION: early 2008 till end June 2009.
24. Holland AE, Hill CJ, Rasekaba T, et al. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010; 91: 221-5.
25. Jones PW, Beeh KM, Chapman KR, et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014; 189: 250-5.
26. Wang Q, Liang X, Wang L, et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 2012; 221:536-43.
27. Heffernan KS, Karas RH, Patvardhan EA, Kuvin JT. Endo-thelium-dependent vasodilation is associated with exercise capacity in smokers and non-smokers. Vasc Med 2010; 15: 119-25.
28. Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001; 38: 1843-9.
29. Patel AR, Kuvin JT, Sliney KA, et al. Peripheral vascular endothelial function correlates with exercise capacity in women. Clin Cardiol 2005; 28: 433-6.
30. Herbst EA, Paglialunga S, Gerling C, et al. Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle. J Physiol 2014; 592 (Pt 6): 1341-52.
31. Ma W, Wu JH, Wang Q, et al. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study. Am J Clin Nutr 2015; 101: 153-63.
32. Mu L, Mukamal KJ, Naqvi AZ. Erythrocyte saturated fatty acids and systemic inflammation in adults. Nutrition 2014; 30: 1404-8.